Heidesheim, Germany

Karl Sturm


Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1977-1984

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Karl Sturm

Introduction

Karl Sturm, an inventive mind based in Heidesheim, Germany, has made significant strides in the field of pharmaceuticals with a total of seven patents to his name. His work focuses on developing compounds that have therapeutic applications, particularly in the area of salidiuretics.

Latest Patents

Among his latest inventions are noteworthy patents such as "5-Phenyltetrazoles and their use as salidiuretics." This patent discloses salidiuretic compounds characterized by specific structural formulas, including their physiologically acceptable salts. The developments underscore methods for synthesizing these compounds, along with their pharmaceutical preparations and applications in treating humans and other mammals.

Another vital patent by Karl Sturm is related to "Base-substituted anthranilic acids, a process for their preparation." This invention details base-substituted anthranilic acids and their physiologically acceptable salts, establishing a process for their synthesis and highlighting their potential as medicaments.

Career Highlights

Karl Sturm has been a prominent figure at Hoechst Aktiengesellschaft, a leading company in the pharmaceutical sector. His innovative contributions significantly advance the company's research and development efforts in medicinal chemistry.

Collaborations

Throughout his impressive career, Sturm has collaborated with several talented individuals, including coworkers Roman Muschaweck and Max Hropot. Together, they have driven forward research initiatives that enhance the understanding and application of medicinal compounds.

Conclusion

Karl Sturm's dedication to innovation in pharmaceuticals is evident in his impressive portfolio of patents. His work not only contributes to advancing medical science but also positively impacts therapeutic options available for various health conditions. Through his collaboration with esteemed colleagues and his role at Hoechst Aktiengesellschaft, he continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…